PFIZER

Pfizer is one of World's Top Pharmaceutical company and its headquarters is in New York, USA. Pfizer Products and Medicines are the results of 1500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription. Pfizer develops medicines from simple diseases to most complex diseases in the world.

Major Acquisitions

Pfizer acquired Wyeth for 68 Billion USD in 2009.

Annual Results Summary:

Pfizer Inc - Yearly Revenue and Net Profit - in Billion USD:

Year - Ending	Revenue	Operating Income	Net Profit	EPS (USD)
Dec-2020	41.91	8.76	9.62
Dec-2019	51.75	13.92	16.27	2.92
Dec-2018	53.65	15.04	11.15	1.90
Dec-2017	52.54	14.10	21.31	4.57
Dec-2016	52.82		7.21	1.18

Balance Sheet Summary

Pfizer Inc - Balance Sheet Summary - in Million USD:

Year Ending:	Total Current Assets	Total Assets	Total Current Liabilities	Total Liabilities	Total Equity
Dec-2020	35,067	154,229	25,920	90,991	63,238
Dec-2019	32,803	167,489	37,304	104,345	63,143
Dec-2018	49,926	159,422	31,858	96,015	63,407
Dec-2017	41,141	171,797	30,427	100,489	71,308
Dec-2016	38,949	171,615	31,115	112,072	59,544

Quarterly Results Summary:

Pfizer Inc - Quarterly Revenue and Net Profit - in Billion USD:

Quarter - Ending	Revenue	Net Profit	EPS (USD)
Sep-2021	24,094	8,146	1.45
Jun-2021	18,977	5,589	1.07
Mar-2021	14,582	4,886	0.93
Dec-2020	5,947	630	0.42
Sep-2020	12.13	2.19	0.72
Jun-2020	11.80	3.42	0.61
Mar-2020	12.03	3.40	0.61
Dec-2019	12.69	(-)0.33 (Loss)	-0.06
Sep-2019	12.68	7.68	1.38
Jun-2019	13.26	5.05	0.88
Mar-2019	13.12	3.88	0.68
Dec-2018	13.98	(-)0.39 (Loss)	-0.05
Sep-2018	13.30	4.11	0.68
Jun-2018	13.47	3.87	0.65

Comments

Pfizer is expanding Phase 3 Trials to test Covid-19 Vaccine

Pfizer and BioNTech planning to expand phase 3 trials to test Covid-19 vaccine. From initial plan of 30,000 people, now they are planning to conduct trials of Covid-19 vaccine on 44,000 people. They are expecting results by Oct-2020 ending.

Sun, 13/09/2020 - 14:58